Endonovo Therapeutics Inc (OTCQB:ENDV.PK)

0.0398
Delayed Data
As of 3:03pm ET
 +0.0028 / +7.62%
Today’s Change
0.02
Today|||52-Week Range
0.13
-31.34%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$14.6M

Company Description

Endonovo Therapeutics, Inc. is a biotechnology company, which engages in developing off bioelectronic approach to regenerative medicine. It operates through the Intellectual Property Management and Commercialization segment. The company was founded on May 26, 2011 and is headquartered in Woodland Hills, CA.

Contact Information

Endonovo Therapeutics, Inc.
6320 Canoga Avenue
Woodland Hills California 91367
P:(800) 701-1223
Investor Relations:
18007011223108

Employees

Shareholders

Individual stakeholders13.08%
Mutual fund holders--
Other institutional--

Top Executives

Alan Brian CollierChairman, CEO, CFO & Secretary
Michael Scott MannPresident
Don CalabriaChief Operating Officer
Leonard MakowkaChief Medical Officer
Steven BarnesSenior Vice President-Investor Relations